Urge your members of Congress to support continued medical research funding
ASH will recognize William Eaton, MD, PhD, and Richard A. Larson, MD, with the 2019 Henry M. Stratton Medal for their seminal contributions to basic and clinical/translational hematology research, respectively.
ASH will recognize Leonard Zon, MD, and Michael R. DeBaun, MD, with the 2019 ASH Mentor Award for their sustained, outstanding commitment to the training and career development of early-career hematologists.
ASH will honor Sriram Krishnaswamy, PhD, and Jeffrey I. Weitz, MD, with the 2019 Ernest Beutler Lecture and Prize for their significant research contributions to the understanding and treatment of blood clots.
ASH will present the 2019 William Dameshek Prize to Emmanuelle Passegué, PhD, of Columbia University Irving Medical Center in New York City for her outstanding contributions to the understanding of hematopoietic stem cells.
ASH will honor Philip Greenberg, MD, of Fred Hutchinson Cancer Research Center and the University of Washington in Seattle with the 2019 E. Donnall Thomas Lecture and Prize for his outstanding contributions to the field of immunotherapy.
ASH will honor Griffin Rodgers, MD, of the National Institute of Diabetes and Digestive and Kidney Diseases in Bethesda, Maryland with the ASH Award for Leadership in Promoting Diversity for his extraordinary commitment to diversity and inclusion in hematology.
ASH will recognize Richard Aster, MD, of the Medical College of Wisconsin and Versiti Blood Center of Wisconsin in Milwaukee with the 2019 Wallace H. Coulter Award for Lifetime Achievement in Hematology.
How slow—or fast—older individuals with blood cancers are able to walk four meters (about 13 feet) holds critical information about their overall health and strongly predicts survival and unplanned hospital visits regardless of age, cancer or treatment type, or other factors, according to a new study published today in Blood.
Hematologists are zeroing in on the escalating humanitarian crisis in southern Europe by assessing the burden of blood disorders among refugees and identifying strategies to facilitate more timely identification and treatment of refugees with sickle cell disease.
Earlier this week, the Centers for Medicare and Medicaid Services (CMS) proposed to improve the reimbursement currently given to hospitals that provide chimeric antigen receptor T-cell (CAR-T) therapy to blood cancer patients as part of the FY 2020 Inpatient Prospective Payment System proposed rule.
Urge your members of Congress to support continued medical research funding.
AMERICAN SOCIETY OF HEMATOLOGY
2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545
by American Society of Hematology